Biotech Sleeper (NWBO) Northwest Biotherapeutics Heats Up as Imminent DCVax-L Phase III Top Line Data Looms Large

Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) has moved back into full beast mode and has been running higher in recent trading on heavy accumulation. NWBO is the darling of small caps and has proven itself as among the most resilient stocks in small caps with a huge following of investors. With a 52-week high of $2.51 and a newly established base over $1 NWBO is holdings its gains with ease and surging higher with power as Investors eagerly await top line data from the Phase III trial of DCVax®-L.